About X4 Pharmaceuticals
Our commitment is to find solutions for patients. Every day, we strive to advance our pipeline of innovative medicines to treat rare diseases.
Our first-in-class, oral, small molecule therapeutics are antagonists of chemokine receptor CXCR4, which have the potential to treat a broad range of rare diseases, including primary immunodeficiencies (PIs) and cancer.
X4 Pharmaceuticals, Inc. was founded and is led by a team with deep product development and commercialization expertise, including several former members of the Genzyme leadership team and has its headquarter located in Cambridge, Massachusetts.
X4’s research and development facility in Vienna, Austria, X4 Pharmaceuticals (Austria) GmbH is located on Campus Vienna Biocenter (Helmut-Qualtinger-Gasse 2, 1030 Vienna) and is run by a team of highly motivated scientists and technicians who are dedicated to build a Center of Research Excellence in the field of small molecule therapeutics.
X4 Pharmaceuticals (Austria) GmbH is currently offering a full-time employment contract for a Scientist Discovery .
The Scientist Discovery will contribute to the identification and validation of novel PID targets and therapeutics, with a focus on WHIM and severe congenital neutropenia.
Main duties will be to :
In accordance with Austrian employment law, the minimum monthly gross salary for the position is EUR 3.428,19 which we are willing to adjust according to your qualifications, skills and expertise.
Please send your resume and cover letter in English.
Please read our X4 Pharmaceuticals (Austria) GmbH Privacy Notice for Applicants , which you will find on our website.